RA Capital Management's Life Science Portfolio

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.

Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.

Bambusa Therapeutics operates as biotechnology company.

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.

Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.

Outpace Bio develops innovative cell therapies to enhance cancer treatment efficacy.

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.

Capacity Bio is a therapeutics company that is focused on mitophagy.

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Zura Bio is a clinical-stage, multi-asset biotechnology company.

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.